Skip to content
Govbase
Govbase
Congress·In Committee·H.R. 4752

Reducing Hereditary Cancer Act

Rep. Wasserman Schultz Leads Bipartisan Push to Expand Medicare Coverage for Cancer Genetic Testing

This bill is currently in the early stages of the legislative process and is being reviewed by two House committees. It is actively moving forward as it waits for these committees to finish their initial study. There are no upcoming votes scheduled at this time.

Legislative Progress

House
Senate
President
Law
Could go either way

The bill has strong bipartisan support and focuses on saving lives through prevention, but the cost of expanding Medicare coverage can make it difficult to pass.

Key Points

Healthcare

Impact Analysis

Personal Impact

Programs

Medicare would begin covering hereditary cancer genetic testing, risk-reducing preventive surgeries, and more frequent cancer screenings for beneficiaries with a family or personal history of hereditary cancer gene mutations. This expands access to potentially life-saving preventive care for an estimated 5-10% of Medicare beneficiaries who may have hereditary cancer risk, though the bill still needs to clear committee and both chambers of Congress.

in the case of an individual with a personal or family history of a hereditary cancer gene mutation or a personal or family history suspicious for hereditary cancer, germline mutation testing
3
2
2
5
+3
ImpactCertaintyScopeDurationSentiment

Disabilities

Milestones

2 milestones2 actions
Jul 23, 2025House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Jul 23, 2025

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Reducing Hereditary Cancer Act

Bill NumberHR 4752
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(27)
D: 20R: 7

Analysis generated by AI. Always verify with official sources.